טוען...
Systemic administration of β(2)-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses
1. β(2)-Adrenoceptor agonists provide a potential therapy for muscle wasting and weakness, but their use may be limited by adverse effects on the heart, mediated in part, by β(1)-adrenoceptor activation. 2. Two β(2)-agonists, formoterol and salmeterol, are approved for treating asthma and have an ex...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group
2006
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1751341/ https://ncbi.nlm.nih.gov/pubmed/16432501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0706669 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|